[144] Merit Medical Systems Inc SEC Filing

Rhea-AI Filing Summary

Merit Medical Systems, Inc. (MMSI) Form 144 notice reports a proposed sale of 3,000 common shares valued at $265,683 to be sold through Morgan Stanley Smith Barney on NASDAQ on 08/22/2025. The filing states these shares were acquired the same day via stock option exercise and paid for in cash. The filer represents no undisclosed material adverse information about the issuer. The filing also lists a prior sale by Lynne Ward of 2,433 shares on 08/11/2025 for $206,535.91. Outstanding shares are listed as 59,219,117.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 notice for an insider option exercise and sale; procedural disclosure, not clearly material.

The filing documents an insider exercise and proposed sale of 3,000 common shares using a broker on NASDAQ with cash payment. The filer affirms no undisclosed material adverse information. The transaction size relative to the 59,219,117 shares outstanding appears small. This is a standard regulatory disclosure to satisfy Rule 144 resale requirements and includes a prior recent sale by the same account.

Equity Research Associate

TL;DR: Insider exercised options and is selling a modest block; informational but not clearly material to valuation.

The record shows acquisition by stock option exercise and immediate disposition through a recognized broker. Aggregate market value is $265,683 which is modest against the stated outstanding share base. The filing provides transaction dates, quantities, and gross proceeds for a recent prior sale, offering transparency on insider liquidity activity without forward-looking detail.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	265683.00	59219117	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/22/2025	Stock Option Exercise	Issuer			3000	08/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
LYNNE WARD 1600 West Merit Parkway South Jordan UT 84095	Common	08/11/2025	2433	206535.91

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Merit Medical's (MMSI) Form 144 report?

The Form 144 reports a proposed sale of 3,000 common shares valued at $265,683, to be sold on 08/22/2025 through Morgan Stanley Smith Barney on NASDAQ.

How were the 3,000 shares acquired according to the filing?

The filing states the shares were acquired on 08/22/2025 via a stock option exercise and payment was made in cash on that date.

Does the Form 144 disclose any undisclosed adverse information about MMSI?

The filer signs a representation stating they do not know any material adverse information regarding Merit Medical that has not been publicly disclosed.

Were there any recent related sales disclosed in the filing?

Yes. The filing lists a prior sale by Lynne Ward of 2,433 shares on 08/11/2025 for $206,535.91.

What broker is handling the proposed sale?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza.